geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Patient access to pharmaceuticals: an international comparison


, : Patient access to pharmaceuticals: an international comparison. European Journal of Health Economics 8(3): 253-266

We have identified eight sub-dimensions of patient access to pharmaceuticals: marketing approvals, time of marketing approval, coverage, cost sharing, conditions of reimbursement, speed from marketing approval to reimbursement, extent to which beneficiaries control choice of their drug benefit, and evenness of the availability of drugs to the population. For a sample of commonly used best-selling drugs in the United States (US), we measured these eight access sub-dimensions across four health systems: France, the Netherlands, the United Kingdom (UK), and the US. Although the US approved between 15 and 18% more drugs than the other three countries, the US was slower than France and the UK to approve drugs licensed in all four countries. The percentage of drugs covered is approximately the same for all four countries. For covered drugs, we observe the least cost sharing by patients in the Netherlands. The Netherlands imposes conditions of reimbursement on a much larger percentage of drugs. France seems to be the slowest in respect of speed from marketing approval to reimbursement. The US is the most flexible in terms of the extent to which beneficiaries control their choice of drug benefit but it is the least universal in terms of evenness of the availability of drugs to the population. Our study confirms the frequently cited problems of access in European countries: lag between marketing approval and reimbursement, and inflexibility in respect of the extent to which beneficiaries control their choice of drug benefit. At the same time, our study confirms, qualitatively, different kinds of access problems in the US: relatively high patient cost sharing for pharmaceuticals, and wide variation in coverage.

US$19.90

PMID: 17279403

DOI: 10.1007/s10198-006-0028-z


Other references

Rath, S.N.; Strobel, L.A.; Arkudas, A.; Beier, J.P.; Maier, A-Kathrin.; Greil, P.; Horch, R.E.; Kneser, U., 2013: Osteoinduction and survival of osteoblasts and bone-marrow stromal cells in 3D biphasic calcium phosphate scaffolds under static and dynamic culture conditions. In many tissue engineering approaches, the basic difference between in vitro and in vivo conditions for cells within three-dimensional (3D) constructs is the nutrition flow dynamics. To achieve comparable results in vitro, bioreactors are advised...

Kruger, Martin, 2003: Out of Africa repeated? On the tribal composition of southern Ennominae and the origin of Geometridae. Spixiana 26(3): 198, 1 November

Whitebread, S., 1981: 1981-Exkursionen in unserem Basler-Gebiet 2 Blauen Reben Blauen-Bergheim Liste der beobachteten bezw gefangenen Lepidopteren. Mitteilungen der Entomologischen Gesellschaft Basel, 314: 117-121

Jacobs, J.A., 1981: The changing climate for credentialing in nursing. Florida Nurse 29(8): 3-6

Shaw, J.S.; Caldamone, A.A.; Rardin, C.R., 2015: Congenital prepubic sinus in an adolescent female: a case report and review of the literature. Congenital prepubic sinus is a rare anomaly, especially in women; only 17 cases in 13 reports were found in the English literature after a search in the PubMed during 1990-2013. We report the diagnosis and successful minimally invasive excision of...

Murphy, A.P.; Rolfe, P., 1992: Intravascular oxygen sensor with polyetherurethane membrane: in vitro performance. Medical & Biological Engineering & Computing 30(1): 121-122

Fritze, H.; Kapanen, A.; Vanhala, P., 1995: Cadmium contamination of wood ash and fire-treated coniferous humus: Effect on soil respiration. Bulletin of Environmental Contamination and Toxicology 54(5): 775-782

Elgavish, A., 1998: Diagnostic test for interstitial cystitis. Official Gazette of the United States Patent & Trademark Office Patents 1215(3): 2975, Oct 20

Heritage, M.L.; Macmillan, J.C.; Anderson, G.J., 2000: Detection and functional analysis of mutations in Jagged1. American Journal of Human Genetics 67(4 Supplement 2): 401, October

Malkovský, M.; Medawar, P.; Hunt, R.; Palmer, L.; Doré, C., 1984: A diet enriched in vitamin A acetate or in vivo administration of interleukin-2 can counteract a tolerogenic stimulus. A conventional diet enriched in retinyl acetate (vitamin A acetate; VAA) or in vivo administration of exogenous interleukin-2 (IL-2) can effectively annul the otherwise tolerogenic stimulus represented by (CBA X C57BL/10ScSn) F1 cells injected int...